Unicancer
↗France (Federated across 20 hospital sites)
Unicancer is the only French hospital federation 100% dedicated to the fight against cancer and serves as the exclusive national hospital network specializing in oncology. It is a federation of 18 French Comprehensive Cancer Centres (FCCCs) plus 2 affiliated establishments, spanning 20 hospital sites across France. As a non-profit organization, Unicancer groups together private healthcare establishments with a public service mission in healthcare, research, and teaching. The organization is structured as both a hospital federation and a health cooperation group (groupement de coopération sanitaire – GCS) managed by the federation. Unicancer operates as the leading academic sponsor of clinical trials in oncology in Europe, promoting 787 active clinical trials and treating over 600,000 patients annually across its network.
CLASSIFICATION
SIZE & FINANCIALS
Employees:10000+
Founded:1945
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Phase 1 through Phase 4 (Clinical trials at all stages)
Lead Drug Stage:Various - Mix of investigational and approved drugs in trials
Modalities:Chemotherapy, Immunotherapy, Checkpoint Inhibitors, Targeted Therapy, Radiotherapy, Combination Therapies
Active Trials:787
Trial Phases:-
CORPORATE STRUCTURE
Key Partnerships:Roche (OncoDataHub collaborative platform, 2021), Flatiron Health (regulatory-grade evidence generation), Ligue nationale contre le cancer (cancer research funding), Fondation ARC (French cancer research foundation), Quinten Health (real-world patient simulator for lung cancer), RaySearch Laboratories (RayStation/RayCare framework agreement, 2023-2024), Multiple pharmaceutical industry companies (ongoing partnerships)
COMPETITION
Position:Leader (Leading academic trial sponsor in Europe for oncology)
Competitors:EORTC (European Organisation for Research and Treatment of Cancer), ASCO (American Society of Clinical Oncology), ESMO (European Society for Medical Oncology), National cancer institutes in other European countries, Pharmaceutical company-sponsored trials
LEADERSHIP
Key Executives:
Jean-Yves Blay - President
Board Members:6 French Comprehensive Cancer Centre Directors (elected for 3-year terms alongside President)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Unicancer. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.